Martin Audran
Datos Biográficos
| ID | 4452997 |
|---|---|
| NOMBRE | Martin Audran |
| NOMBRES | Martin |
| APELLIDO | Audran |
| FIRMA | AUDRAN M |
| AFILIACIONES | Centre National de la Recherche Scientifique |
| VERIFICADO | No |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Impact of the Covid-19 pandemic on cannabis cultivation and use in 18 countries
This study is the first to document an increase in cannabis cultivation activity following COVID restrictions. Increased home cultivation was not only driven by higher use as a result of home isolation, but also by disruptions of wider illegal cannabis supply. Limitations of this study include the non-representativeness of the sample as well as differences in approaches and duration of restrictions in different countries
Exploration des déterminants bio-psycho-sociaux des niveaux de sévérité du trouble de l’usage d’opioïdes
Au cours des dernières décennies, il a été montré que le trouble de l’usage d’opioïdes (TUO) résultait des effets combinés de nombreux facteurs, notamment psychosociaux et neurobiologiques. Cette pluralité s’incarne dans un cadre théorique global : le modèle biopsychosocial de l’addiction. Si l’impact de chaque facteur sur la sévérité du TUO a été bien identifié, leur action combinée n’est pas connue. Dans ce contexte, le projet multidisciplinair…
Medications for Opioid Use Disorder in People Who Inject Substances
BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the preval…
Sin obras prominentes en esta página.
Medications for Opioid Use Disorder in People Who Inject Substances
BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the preval…
Impact of the Covid-19 pandemic on cannabis cultivation and use in 18 countries
This study is the first to document an increase in cannabis cultivation activity following COVID restrictions. Increased home cultivation was not only driven by higher use as a result of home isolation, but also by disruptions of wider illegal cannabis supply. Limitations of this study include the non-representativeness of the sample as well as differences in approaches and duration of restrictions in different countries
Exploration des déterminants bio-psycho-sociaux des niveaux de sévérité du trouble de l’usage d’opioïdes
Au cours des dernières décennies, il a été montré que le trouble de l’usage d’opioïdes (TUO) résultait des effets combinés de nombreux facteurs, notamment psychosociaux et neurobiologiques. Cette pluralité s’incarne dans un cadre théorique global : le modèle biopsychosocial de l’addiction. Si l’impact de chaque facteur sur la sévérité du TUO a été bien identifié, leur action combinée n’est pas connue. Dans ce contexte, le projet multidisciplinair…
Medicine (3 obras) · HIV, Drug Use, Sexual Risk (2 obras) · Opioid Use Disorder Treatment (2 obras) · Psychiatry (2 obras) · 2019-20 coronavirus outbreak (1 obras) · Addiction (1 obras) · Buprenorphine (1 obras) · Cannabis (1 obras) · Cannabis and Cannabinoid Research (1 obras) · Cohort (1 obras)